AMERICAN GENE ENGINEER CORP
company.status.inactiveCIK 1600784fmd_1BF897BKFTP9Y87X31X7KQD522Finance, Insurance and Real Estate · Blank ChecksTemplate: Standard
Coverage: Nov 01, 2012 to Apr 30, 2018, 20 periods
Latest annual · FY2014
Millions- Total revenues
- 0
- Net income
- (0)
Latest quarter · Q2 FY2018
Millions- Net income
- (0)
AMERICAN GENE ENGINEER CORP financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2017 | FY2016 | Change | Source |
|---|---|---|---|---|
| Net income | -$362,176 | -$240,000 | 10-K 2018-02-21 · proof | |
| Cash from operating activities | -$337,679 | $248,507 | -235.9% | 10-K 2018-02-21 · proof |
| Total assets | $84,575 | $404,698 | -79.1% | 10-K 2018-02-21 · proof |
| Total liabilities | $599,292 | $586,824 | +2.1% | 10-K 2018-02-21 · proof |
| Cash and cash equivalents | $447 | $308,541 | -99.9% | 10-K 2018-02-21 · proof |
- What was AMERICAN GENE ENGINEER CORP's net income in fiscal 2017?
- AMERICAN GENE ENGINEER CORP reported net income of -$362,176 for fiscal 2017 (the year ended Oct 31, 2017), against -$240,000 the year before. Source: the 10-K filed with the SEC on Feb 21, 2018. SEC
- What was AMERICAN GENE ENGINEER CORP's cash from operating activities in fiscal 2017?
- AMERICAN GENE ENGINEER CORP reported cash from operating activities of -$337,679 for fiscal 2017 (the year ended Oct 31, 2017), against $248,507 the year before (-235.9%). Source: the 10-K filed with the SEC on Feb 21, 2018. SEC
- What are AMERICAN GENE ENGINEER CORP's total assets?
- As of Oct 31, 2017, AMERICAN GENE ENGINEER CORP reported total assets of $84,575, against $404,698 a year earlier (-79.1%). Source: the 10-K filed with the SEC on Feb 21, 2018. SEC
- What are AMERICAN GENE ENGINEER CORP's total liabilities?
- As of Oct 31, 2017, AMERICAN GENE ENGINEER CORP reported total liabilities of $599,292, against $586,824 a year earlier (+2.1%). Source: the 10-K filed with the SEC on Feb 21, 2018. SEC
- What are AMERICAN GENE ENGINEER CORP's cash and cash equivalents?
- As of Oct 31, 2017, AMERICAN GENE ENGINEER CORP reported cash and cash equivalents of $447, against $308,541 a year earlier (-99.9%). Source: the 10-K filed with the SEC on Feb 21, 2018. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1600784&period_type=annual&limit=5"Information only, not investment advice.